Jinhe Biotechnology Co. Ltd.
Status: Publicly traded
Direct answer
Jinhe Biotechnology Co. Ltd. is publicly traded on SHZ under the ticker 002688.SZ.
Founded in 1990 and headquartered in Dalian, China, Jinhe Biotechnology Co. Ltd. focuses on the development and distribution of animal health pharmaceuticals both domestically and internationally. The company provides chlortetracycline in a feed-grade formulation, an antimicrobial compound vital for preventing and treating conditions like white dysentery, enteritis, pneumonia, typhoid, paratyphoid, and cholera in...
Can you invest in Jinhe Biotechnology Co. Ltd.?
Yes. Jinhe Biotechnology Co. Ltd. trades publicly on SHZ as 002688.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jinhe Biotechnology Co. Ltd.
Detailed equity research is provided by MarketSnap.